Search research articles
Contact Us
Filters
Showing results (511-520 of 522) with videos related to
Page
of 53
Sort By:
European Urology
|
December 9, 2020
A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer
Neil K Jairath, Alan Dal Pra, Randy Vince, et al.
JAMA Oncology
|
May 24, 2019
Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality
Robert T Dess, Holly E Hartman, Brandon A Mahal, et al.
European Urology
|
March 15, 2026
A Phase 2, Randomized, Controlled Trial of Best Systemic Therapy Versus Best Systemic Therapy with Definitive Treatment of the Primary Tumor in Metastatic Prostate Cancer
Brian F Chapin, Marc Smaldone, Amado J Zurita, et al.
JAMA Network Open
|
January 16, 2026
Docetaxel Rechallenge vs Cabazitaxel in Patients With Metastatic Castration-Resistant Prostate Cancer
Pedro C Barata, June K Corrigan, Jennifer La, et al.
JAMA Oncology
|
November 20, 2025
Magnetic Resonance Imaging or Confirmatory Biopsy for Patients With Prostate Cancer Receiving Active Surveillance
Matthew R Cooperberg, John R Bihn, John M Culnan, et al.
The Journal of Urology
|
April 28, 2026
Non-Invasive Urine Test Predicts Grade Group Upgrading in Patients on Active Surveillance for Prostate Cancer: Multisite Validation and Comparison with MRI
Jeffrey J Tosoian, Jacob I Meyers, Bradley Moore, et al.
JU Open Plus
|
May 22, 2024
Expert Perspectives on Controversies in Castration-Sensitive Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 1
E David Crawford, Alan H Bryce, Maha H Hussain, et al.
JU Open Plus
|
May 22, 2024
Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2
Alan H Bryce, E David Crawford, Neeraj Agarwal, et al.
Cancer Discovery
|
December 9, 2024
Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer
Lisa N Chesner, Fanny Polesso, Julie N Graff, et al.
European Urology Oncology
|
January 29, 2023
Best Current Practice and Research Priorities in Active Surveillance for Prostate Cancer-A Report of a Movember International Consensus Meeting
Caroline M Moore, Lauren E King, John Withington, et al.
Page
of 53
Search research articles
Search
Showing results (511-520 of 522) with videos related to
Sort By:
Page
of 53
European Urology
|
December 9, 2020
A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer
Neil K Jairath, Alan Dal Pra, Randy Vince, et al.
JAMA Oncology
|
May 24, 2019
Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality
Robert T Dess, Holly E Hartman, Brandon A Mahal, et al.
European Urology
|
March 15, 2026
A Phase 2, Randomized, Controlled Trial of Best Systemic Therapy Versus Best Systemic Therapy with Definitive Treatment of the Primary Tumor in Metastatic Prostate Cancer
Brian F Chapin, Marc Smaldone, Amado J Zurita, et al.
JAMA Network Open
|
January 16, 2026
Docetaxel Rechallenge vs Cabazitaxel in Patients With Metastatic Castration-Resistant Prostate Cancer
Pedro C Barata, June K Corrigan, Jennifer La, et al.
JAMA Oncology
|
November 20, 2025
Magnetic Resonance Imaging or Confirmatory Biopsy for Patients With Prostate Cancer Receiving Active Surveillance
Matthew R Cooperberg, John R Bihn, John M Culnan, et al.
The Journal of Urology
|
April 28, 2026
Non-Invasive Urine Test Predicts Grade Group Upgrading in Patients on Active Surveillance for Prostate Cancer: Multisite Validation and Comparison with MRI
Jeffrey J Tosoian, Jacob I Meyers, Bradley Moore, et al.
JU Open Plus
|
May 22, 2024
Expert Perspectives on Controversies in Castration-Sensitive Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 1
E David Crawford, Alan H Bryce, Maha H Hussain, et al.
JU Open Plus
|
May 22, 2024
Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2
Alan H Bryce, E David Crawford, Neeraj Agarwal, et al.
Cancer Discovery
|
December 9, 2024
Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer
Lisa N Chesner, Fanny Polesso, Julie N Graff, et al.
European Urology Oncology
|
January 29, 2023
Best Current Practice and Research Priorities in Active Surveillance for Prostate Cancer-A Report of a Movember International Consensus Meeting
Caroline M Moore, Lauren E King, John Withington, et al.
Page
of 53